Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2013 2
2014 1
2015 2
2016 3
2017 6
2018 4
2019 3
2020 2
2021 1
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. Neal B, et al. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605608 Free article. Clinical Trial.
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.
Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJ; ODYSSEY LONG TERM Investigators. Robinson JG, et al. N Engl J Med. 2015 Apr 16;372(16):1489-99. doi: 10.1056/NEJMoa1501031. Epub 2015 Mar 15. N Engl J Med. 2015. PMID: 25773378 Free article. Clinical Trial.
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators. Hernandez AF, et al. Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2. Lancet. 2018. PMID: 30291013 Clinical Trial.
Accelerated vascular age in adolescents with primary hypertension.
Obrycki Ł, Sarnecki J, Pac M, Dereziński T, Lewandowska W, Feber J, Litwin M. Obrycki Ł, et al. Among authors: derezinski t. J Hypertens. 2023 Jan 1;41(1):171-179. doi: 10.1097/HJH.0000000000003318. Epub 2022 Nov 2. J Hypertens. 2023. PMID: 36441851
Kidney length normative values in children aged 0-19 years - a multicenter study.
Obrycki Ł, Sarnecki J, Lichosik M, Sopińska M, Placzyńska M, Stańczyk M, Mirecka J, Wasilewska A, Michalski M, Lewandowska W, Dereziński T, Pac M, Szwarc N, Annusewicz K, Rekuta V, Ažukaitis K, Čekuolis A, Wierzbicka-Rucińska A, Jankauskiene A, Kalicki B, Jobs K, Tkaczyk M, Feber J, Litwin M. Obrycki Ł, et al. Among authors: derezinski t. Pediatr Nephrol. 2022 May;37(5):1075-1085. doi: 10.1007/s00467-021-05303-5. Epub 2021 Oct 16. Pediatr Nephrol. 2022. PMID: 34657197 Free PMC article.
Kidney length normative values - new percentiles by age and body surface area in Central European children and adolescents.
Obrycki Ł, Sarnecki J, Lichosik M, Sopińska M, Placzyńska M, Stańczyk M, Mirecka J, Wasilewska A, Michalski M, Lewandowska W, Dereziński T, Pac M, Szwarc N, Annusewicz K, Rekuta V, Ažukaitis K, Čekuolis A, Wierzbicka A, Jankauskiene A, Kalicki B, Jobs K, Tkaczyk M, Feber J, Litwin M. Obrycki Ł, et al. Among authors: derezinski t. Pediatr Nephrol. 2023 Apr;38(4):1187-1193. doi: 10.1007/s00467-022-05667-2. Epub 2022 Aug 8. Pediatr Nephrol. 2023. PMID: 35939143
24 results